Clinical Trial Update: Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update for Stem Cell Educator Therapy addressing viral inflammation in COVID-19-related severe pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome Pneumonia

Drugs mentioned

• Stem Cell Educator Therapy

Snippet

Sponsor: Throne Biotechnologies Inc. | Conditions: Severe Acute Respiratory Syndrome (SARS) Pneumonia | Phase 2 | Status: UNKNOWN